PC4PrEP: Integrating PrEP Into Primary Care (PC4PrEP)
Human Immunodeficiency Virus Transmission
About this trial
This is an interventional other trial for Human Immunodeficiency Virus Transmission focused on measuring Pre-exposure prophylaxis, Human Immunodeficiency Virus, PrEP, Risk for HIV acquisition, PrEP candidacy
Eligibility Criteria
Inclusion Criteria:
- Patient at Montefiore Medical Center or Bronx Community Based Organization (CBO)
- Assessed to be eligible for PrEP by PCP
- Willing to provide dried blood spot (DBS) samples for antiretroviral anabolite testing
- Willing to provide access to medical records
- Willing to have interview audio-recorded
- No grossly evident cognitive impairment precluding consent and participation
- Speaks Spanish or English
Exclusion Criteria:
- Less than 18 years of age
- Not a patient at Montefiore Medical Center or Bronx Community Based Organization (CBO)
- Assessed to be ineligible for PrEP by PCP
- Unwilling to provide dried blood spot samples for ARV anabolite testing
- Unwilling to provide access to medical records
- Unwilling to have interview audio-recorded
- Unable to provide informed consent due to grossly evident cognitive impairment
- Does not speak Spanish or English
Sites / Locations
- Albert Einstein College of Medicine
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
PC4PrEP- Intervention Clinics
Standard of Care Clinics
Intervention clinics will receive the PC4PrEP intervention. The intervention includes Montefiore PrEP policy awareness, provider and patient education, pre-screening to identify PrEP eligible patients, and identifying high risk individuals in the community and providing referral and linkage to primary care.
These clinics will not receive the PC4PrEP intervention but will continue with their standard of care model.